Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
Glycosphingolipids (GSLs) hexosylceramides and lactosylceramides are elevated in lupus mice and human patients with nephritis. Whereas other renal diseases characterized by increased GSL levels are thought to be a result of upregulated GSL synthesis, our results suggest elevated hexosylceramides and...
Main Authors: | Tamara K Nowling, Jessalyn Rodgers, Thirumagal Thiyagarajan, Bethany Wolf, Evelyn Bruner, Kamala Sundararaj, Ivan Molano, Gary Gilkeson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230499 |
Similar Items
-
Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
by: Erin Morris Richard, et al.
Published: (2013-01-01) -
ALW peptide ameliorates lupus nephritis in MRL/lpr mice
by: Huixia Wang, et al.
Published: (2019-12-01) -
The Immunological Modulated Effects of Longdan Xiegan Tang on Systemic Lupus Erythematousus of MRL lpr/lpr Mice
by: Wen Tsung Kai, et al.
Published: (2006) -
The MRL/lpr Mouse Strain as a Model for Neuropsychiatric Systemic Lupus Erythematosus
by: Maria Gulinello, et al.
Published: (2011-01-01) -
The Therapeutic Effects of the Chinese Herbal Medicine, Lang Chuang Fang Granule, on Lupus-Prone MRL/lpr Mice
by: Kai-Peng Huang, et al.
Published: (2016-01-01)